Subtopic Deep Dive

← Piperaceae Chemical and Biological Studies

Piperine Neuroprotective Properties
Research Guide

What is Piperine Neuroprotective Properties?

Piperine Neuroprotective Properties examines piperine's protective effects against neurodegeneration in Parkinson's and Alzheimer's models through antioxidant mechanisms and monoamine oxidase inhibition.

Research demonstrates piperine's neuroprotection in MPTP-induced Parkinson's mouse models via reduced oxidative stress (Yang et al., 2015, 99 citations). Studies also highlight its role in alleviating scopolamine-induced memory impairment in rats using black pepper oil (Mostafa et al., 2021, 55 citations). Over 10 papers from 2015-2023, with 169 citations for the most cited review (Tripathi et al., 2022).

Curated Papers

Key Challenges

Why It Matters

Piperine offers dietary neuroprotection against Parkinson's via dopaminergic neuron preservation in MPTP models (Yang et al., 2015). In Alzheimer's models, black pepper compounds mitigate oxidative stress and memory deficits (Mostafa et al., 2021; Sharma et al., 2023). Clinical trial evidence supports its disease management potential (Tripathi et al., 2022), addressing unmet needs in neurodegeneration with accessible interventions from Piper nigrum.

Key Research Challenges

Translational Clinical Gaps

Most evidence derives from rodent models like MPTP-PD mice, lacking human trials (Yang et al., 2015; Tripathi et al., 2022). Piperine's low bioavailability limits therapeutic dosing despite clinical trial mentions. Bridging preclinical to human efficacy remains unresolved.

Mechanism Specificity

Antioxidant and MAO inhibition effects overlap with piperine metabolites, complicating attribution (Azam et al., 2022). Network pharmacology identifies targets but requires validation in neuronal cultures (Choudhary and Singh, 2018). Isolating piperine's unique pathways from black pepper extracts challenges research.

Dose-Dependent Toxicity

High doses in LPS-induced inflammation models protect neurons but risk toxicity (He et al., 2016). Balancing neuroprotective benefits with safety in age-related models needs optimization (Balakrishnan et al., 2022). Long-term dietary intake effects lack longitudinal studies.

Essential Papers

Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials

Amit Kumar Tripathi, Anup Kumar Ray, Sunil Kumar Mishra · 2022 · Beni-Suef University Journal of Basic and Applied Sciences · 169 citations

Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model

Wei Yang, Yuhua Chen, Hao Liu et al. · 2015 · International Journal of Molecular Medicine · 99 citations

Parkinson's disease (PD) is second only to Alzheimer's disease as the most common and debilitating age-associated neurodegenerative disorder. Currently, no therapy has been shown to unequivocally r...

A census of P. longum’s phytochemicals and their network pharmacological evaluation for identifying novel drug-like molecules against various diseases, with a special focus on neurological disorders

Neha Choudhary, Vikram Singh · 2018 · PLoS ONE · 64 citations

Piper longum (P. longum, also called as long pepper) is one of the common culinary herbs that has been extensively used as a crucial constituent in various indigenous medicines, specifically in tra...

Neuroprotective Effects of Black Pepper Cold-Pressed Oil on Scopolamine-Induced Oxidative Stress and Memory Impairment in Rats

Nada M. Mostafa, Ahmed M. Mostafa, Mohamed L. Ashour et al. · 2021 · Antioxidants · 55 citations

Oxidative stress is usually associated with many neurodegenerative diseases. In this study, the gas chromatography–mass spectrometry (GC–MS) analysis of cold-pressed oil (CPO) from black pepper (Pi...

Piperine and Its Metabolite’s Pharmacology in Neurodegenerative and Neurological Diseases

Shofiul Azam, Ju‐Young Park, In‐Su Kim et al. · 2022 · Biomedicines · 45 citations

Piperine (PIP) is an active alkaloid of black and long peppers. An increasing amount of evidence is suggesting that PIP and its metabolite’s could be a potential therapeutic to intervene different ...

Neuroprotective Effects of Black Pepper and Its Bioactive Compounds in Age-Related Neurological Disorders

Rengasamy Balakrishnan, Shofiul Azam, In‐Su Kim et al. · 2022 · Aging and Disease · 41 citations

Age-related neurological disorders (ANDs), including neurodegenerative diseases, are multifactorial disorders whose risk increases with age. The main pathological hallmarks of ANDs include behavior...

Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide

Huan He, Wei-Wei Guo, Rong-Rong Xu et al. · 2016 · BMC Complementary and Alternative Medicine · 36 citations

Reading Guide

Foundational Papers

No pre-2015 foundational papers available; start with highest-cited Yang et al. (2015) for MPTP-PD mouse model as baseline experimental evidence.

Recent Advances

Tripathi et al. (2022) for clinical perspectives; Azam et al. (2022) and Balakrishnan et al. (2022) for metabolite and age-related insights; Sharma et al. (2023) for anti-glycation updates.

Core Methods

MPTP mouse models for PD (Yang et al., 2015); scopolamine rat assays for memory (Mostafa et al., 2021); GC-MS for black pepper oil (Mostafa et al., 2021); network pharmacology (Choudhary and Singh, 2018).

How PapersFlow Helps You Research Piperine Neuroprotective Properties

Discover & Search

Research Agent uses searchPapers and exaSearch to find piperine-PD papers like Yang et al. (2015), then citationGraph reveals 99 citing works on MPTP models and findSimilarPapers uncovers Mostafa et al. (2021) for Alzheimer's analogs.

Analyze & Verify

Analysis Agent applies readPaperContent to extract antioxidant data from Yang et al. (2015), verifies claims with CoVe against Tripathi et al. (2022), and runs PythonAnalysis for meta-analysis of citation impacts using pandas on 10 papers' metrics; GRADE scores evidence as moderate due to model limitations.

Synthesize & Write

Synthesis Agent detects gaps in human trials via gap detection on Azam et al. (2022), flags contradictions in bioavailability, and uses exportMermaid for antioxidant pathway diagrams; Writing Agent employs latexEditText, latexSyncCitations for 169-cited Tripathi review, and latexCompile for publication-ready reviews.

Use Cases

"Analyze piperine dosage effects across MPTP Parkinson's papers with statistics."

Research Agent → searchPapers('piperine MPTP') → Analysis Agent → readPaperContent(Yang 2015) + runPythonAnalysis(pandas dose-response meta-analysis) → statistical summary table of EC50 values and p-values.

"Draft LaTeX review on piperine neuroprotection with citations and figures."

Synthesis Agent → gap detection → Writing Agent → latexEditText(intro) → latexSyncCitations(Tripathi 2022, Yang 2015) → latexGenerateFigure(oxidative stress pathway) → latexCompile → PDF review manuscript.

"Find GitHub repos with code for piperine network pharmacology simulations."

Research Agent → paperExtractUrls(Choudhary 2018) → Code Discovery → paperFindGithubRepo → githubRepoInspect → exported Python scripts for phytochemical target prediction networks.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ piperine papers, chaining searchPapers → citationGraph → GRADE grading for MPTP model strength. DeepScan applies 7-step analysis with CoVe checkpoints to verify Azam et al. (2022) metabolite claims against Yang et al. (2015) data. Theorizer generates hypotheses on piperine-MAOB interactions from Tripathi et al. (2022) clinical evidence.

Try Doxa for Piperine Neuroprotective Properties Research

Frequently Asked Questions

What defines Piperine Neuroprotective Properties?

Piperine's neuroprotective effects target Parkinson's and Alzheimer's via antioxidant defense and MAO inhibition in MPTP mouse models and neuronal cultures (Yang et al., 2015).

What are key methods in piperine neuroprotection studies?

Methods include MPTP-induced PD mouse behavioral assays (Yang et al., 2015), scopolamine rat memory tests (Mostafa et al., 2021), and network pharmacology for targets (Choudhary and Singh, 2018).

What are the most cited papers?

Tripathi et al. (2022, 169 citations) reviews clinical trials; Yang et al. (2015, 99 citations) shows MPTP-PD protection; Mostafa et al. (2021, 55 citations) demonstrates memory enhancement.

What open problems exist?

Human clinical trials, bioavailability enhancement, and long-term toxicity in dietary doses remain unaddressed (Tripathi et al., 2022; Azam et al., 2022).